Chronic inflammation and sarcopenia: A regenerative cell therapy perspective

Jagadish K. Chhetri, Philipe de Souto Barreto, Bertrand Fougère, Yves Rolland, Bruno Vellas, Matteo Cesari

Research output: Contribution to journalShort survey

8 Citations (Scopus)

Abstract

Sarcopenia is characterized by reduced skeletal muscle mass and strength in older individuals. It is one of the leading cause of physical limitation in older adults, and associated with wide spectrum of adverse events including disability and mortality. The phenomenon of chronic-inflammation or inflamm-aging with aging is known to be a major contributor to myriad of geriatric conditions including sarcopenia. Recent advances in regenerative medicine, in particular cell therapy have opened up new possibilities to ameliorate broad range of inflammatory disorders. In this context, we will discuss on possibilities of modulation of the chronic-inflammatory activation in older adults using regenerative cell therapy strategies. This review is an effort toward reducing the growing burden of sarcopenia related disability and dependency in the aging population.

Original languageEnglish
Pages (from-to)115-123
Number of pages9
JournalExperimental Gerontology
Volume103
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Sarcopenia
Cell- and Tissue-Based Therapy
Aging of materials
Inflammation
Geriatrics
Regenerative Medicine
Muscle Strength
Muscle
Skeletal Muscle
Chemical activation
Modulation
Mortality
Population

Keywords

  • Aging
  • Cell therapy
  • Chronic inflammation
  • Inflamm-aging
  • Mesenchymal stem cells
  • Mesenchymal stromal cells
  • Regenerative medicine
  • Sarcopenia
  • Stem cells

ASJC Scopus subject areas

  • Biochemistry
  • Ageing
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology

Cite this

Chronic inflammation and sarcopenia : A regenerative cell therapy perspective. / Chhetri, Jagadish K.; de Souto Barreto, Philipe; Fougère, Bertrand; Rolland, Yves; Vellas, Bruno; Cesari, Matteo.

In: Experimental Gerontology, Vol. 103, 01.03.2018, p. 115-123.

Research output: Contribution to journalShort survey

Chhetri, JK, de Souto Barreto, P, Fougère, B, Rolland, Y, Vellas, B & Cesari, M 2018, 'Chronic inflammation and sarcopenia: A regenerative cell therapy perspective', Experimental Gerontology, vol. 103, pp. 115-123. https://doi.org/10.1016/j.exger.2017.12.023
Chhetri, Jagadish K. ; de Souto Barreto, Philipe ; Fougère, Bertrand ; Rolland, Yves ; Vellas, Bruno ; Cesari, Matteo. / Chronic inflammation and sarcopenia : A regenerative cell therapy perspective. In: Experimental Gerontology. 2018 ; Vol. 103. pp. 115-123.
@article{52eff5e0892f4d14a001a77e4536844f,
title = "Chronic inflammation and sarcopenia: A regenerative cell therapy perspective",
abstract = "Sarcopenia is characterized by reduced skeletal muscle mass and strength in older individuals. It is one of the leading cause of physical limitation in older adults, and associated with wide spectrum of adverse events including disability and mortality. The phenomenon of chronic-inflammation or inflamm-aging with aging is known to be a major contributor to myriad of geriatric conditions including sarcopenia. Recent advances in regenerative medicine, in particular cell therapy have opened up new possibilities to ameliorate broad range of inflammatory disorders. In this context, we will discuss on possibilities of modulation of the chronic-inflammatory activation in older adults using regenerative cell therapy strategies. This review is an effort toward reducing the growing burden of sarcopenia related disability and dependency in the aging population.",
keywords = "Aging, Cell therapy, Chronic inflammation, Inflamm-aging, Mesenchymal stem cells, Mesenchymal stromal cells, Regenerative medicine, Sarcopenia, Stem cells",
author = "Chhetri, {Jagadish K.} and {de Souto Barreto}, Philipe and Bertrand Foug{\`e}re and Yves Rolland and Bruno Vellas and Matteo Cesari",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.exger.2017.12.023",
language = "English",
volume = "103",
pages = "115--123",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Chronic inflammation and sarcopenia

T2 - A regenerative cell therapy perspective

AU - Chhetri, Jagadish K.

AU - de Souto Barreto, Philipe

AU - Fougère, Bertrand

AU - Rolland, Yves

AU - Vellas, Bruno

AU - Cesari, Matteo

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Sarcopenia is characterized by reduced skeletal muscle mass and strength in older individuals. It is one of the leading cause of physical limitation in older adults, and associated with wide spectrum of adverse events including disability and mortality. The phenomenon of chronic-inflammation or inflamm-aging with aging is known to be a major contributor to myriad of geriatric conditions including sarcopenia. Recent advances in regenerative medicine, in particular cell therapy have opened up new possibilities to ameliorate broad range of inflammatory disorders. In this context, we will discuss on possibilities of modulation of the chronic-inflammatory activation in older adults using regenerative cell therapy strategies. This review is an effort toward reducing the growing burden of sarcopenia related disability and dependency in the aging population.

AB - Sarcopenia is characterized by reduced skeletal muscle mass and strength in older individuals. It is one of the leading cause of physical limitation in older adults, and associated with wide spectrum of adverse events including disability and mortality. The phenomenon of chronic-inflammation or inflamm-aging with aging is known to be a major contributor to myriad of geriatric conditions including sarcopenia. Recent advances in regenerative medicine, in particular cell therapy have opened up new possibilities to ameliorate broad range of inflammatory disorders. In this context, we will discuss on possibilities of modulation of the chronic-inflammatory activation in older adults using regenerative cell therapy strategies. This review is an effort toward reducing the growing burden of sarcopenia related disability and dependency in the aging population.

KW - Aging

KW - Cell therapy

KW - Chronic inflammation

KW - Inflamm-aging

KW - Mesenchymal stem cells

KW - Mesenchymal stromal cells

KW - Regenerative medicine

KW - Sarcopenia

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85041193177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041193177&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2017.12.023

DO - 10.1016/j.exger.2017.12.023

M3 - Short survey

AN - SCOPUS:85041193177

VL - 103

SP - 115

EP - 123

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

ER -